Worg Pharmaceuticals is a clinical-stage biopharmaceutical company developing new treatments for allergies and other diseases. The company is building a pipeline for allergy and autoimmune diseases based on two technology platforms, PCFiT and Apitope, through internal development and external collaboration with flexible business models. Worg is also developing a platform for molecular allergy diagnosis.